1/66
Looks like no tags are added yet.
Name | Mastery | Learn | Test | Matching | Spaced |
|---|
No study sessions yet.
first generation antihistamines
diphenhydramine (Benadryl) and hydroxizine (Atarax)
second generation antihistamines
loratidine (Claritin), cetirizine (Zyrtec), and Fexofenadine (Allegra, possibly 3rd gen)
first gen antihistamine side effects
xerostomia, sedation, drowsiness
decongestants (like Sudafed) are
alpha-adrenergic agonists
decongestants may
contribute to hypertension/high HR, peripheral vasoconstriciton, and xerostomia
topical decongestants
is a selective alpha adrenergic, modulates arachidonic acid (ex. oxymetazoline (Afrin)
antitussive example
dextromethorphan (Delsym)
antitussives (like delsym) are
NMDA receptor agonists, raises cough threshold, as strong as opioids, can lead to drowsiness/hallucinations
expectorants
clear mucous from airways, irritates gastric vagal receptors, increases respiratory fluid secretions, reduces viscosity (clearance helps remove debris)
expectorant example
guaifenesin (Mucinex)
influenza example
oseltamivir (Tamiflu)
oseltamivir
inhibits neuraminidase, prevents budding, prevents replication (may cause nausea or vomiting, needs refrigerated) doesn’t replace vaccine
RSV examples
ribavirin, nirsevimab, and palivizumab
ribavirin
prevents mRNA synthesis, aerosolized for children/autoimmune patients
nirsevimab and palivizumab given to
lower chances of developing RSV
COVID examples
paxlovid (nirmatrelvir)+ritonavir, Veklury (remdesivir), Olumiant (baricitinib)+Actemra(tocilizumab)
paxlovid (nirmatrelvir)+ritonavir
for COVID outpatient
Veklury (remdesivir) for
IV infusion for hospitalized COVID patients (children or elderly)
Olumiant (baricitinib) +Actemra(tocilizumab) for
IV infusion for hospitalized COVID adults
varicella zoster (chickenpox)
takes 1-2 weeks to clear, calamine lotion to help itch (has live attentuated vaccine)
varicella zoster (shingles) antiviral medications
acyclovir (zovirax), valacyclovir (valtrex), and famciclovir (famvir)
shingrix
shingles recombinant vaccine for over 50 year olds
measles/mumps vaccine is
live attentuated
mumps
caused by paramyxovirus, effects parotid glands, causes cheek swelling,
rubella (german measles)
rubivirus, not as contagious, can cause deafness, heart defects, and retardation (rash behind ear)
polio
from contaminated food/water, spinal nerve damage
HIV
spread via bodily fluids (not saliva), targets CD4 lymphocytes,
HIV therapy initiated
asap, when CD4 <350
nucleoside reverse transcriptase inhibitors (NRTI’s)
inhibits by mimicking nucleosides which integrate into complementary DNA, terminating elongation (reduces neonatal HIV)
NRTI example
zidovudine (retrovir) first HIV medication
NRTI combo example
lamivudine and zidovudine (combivir)
NRTI oral side effects
xerostomia, erythema multiforme, ulcers, and facial lipoatrophy
Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTI’s)
inhibits reverse transcriptase by binding to enzyme by active site (cyt p450)
NNRTI examples
efavirenz (Sustiva) and Etravirine (Intelence)
NNRTI caution
reduces benzodiazepine effficacy/metabolism (resistance may occur)
NNRTI oral side effects
xerostomia, erythema multiforme (more than NRTI), and ulcers
protease inhibitors
slow HIV progression by blocking protease (used by HIV to mature), prevents the virus copying itself
protease inhibitor examples
ritonavir (norvir) and saquinavir (invirase)
protease inhibitor oral effects
altered taste, parotid lipomatosis, xerostomia, and perioral lipomatosis (reduces oral candidiasis)
protease inhibitor interactions
don’t take with benzodiazepines, fluconazole, or ketoconazole (prevents protease inhibitors)
fusion inhibitors
blocks virus from merging with CD4, binds to gp41 of virus that allows attachment, resistance can occur
fusion inhibitor example
enfuvirtide (fuzeon)
fusion inhibitor oral effects
xerostomia, gingivitis, and altered taste
integrase strand transfer inhibitors (INST’s)
block integrase that inserts viral DNA into CD4
INST example
bictegravir (Biktarvy)
CCR5 inhibitor
receptor that allows viral HIV to attach to CD4, entry inhibitor (can dilate neck veins)
CCR5 example
Maraviroc (Selzentry), don’t use antifungals with this
pharmacokinetic enhancers (PK)
non antiretroviral, CYP3a inhibitor, slows metabolism/increases efficacy of other HIV drugs
PK examples
Cobicistat (Tybost) and Ritonivir can as well (Norvir)
highly active antiretroviral therapy (HAART)
combos of meds (cocktails) in low doses (protease inhibitor+2 NRTIs OR NNRTI+2 NRTIs)
pre-exposure prophylaxis (PrEP)
reduces contraction risk from sex by 99% and from injection by 74%
post-exposure prophlyaxis
risk lowered by 80% within 72 hours done asap, take meds for 28 days
Hep C use
protease inhibitors as first drug (interacts with azoles, benzos, prednisone, and clarithromycin)
Hep C Oral effects
intraoral (bruising, gingivitis, xerostoma, jaundice), decreased clotting=more bleeding (consult, no acetaminophen/NSAIDS)
Hep B vaccine
recombinant DNA vaccine
Hep B treatments
interferons (Roferon-A) not a cure
HPV vaccine
recombinant vaccine
HSV-1 symptoms
primary herpetic gingivastomatitis
HSV-1 primary infection treatments
acetaminophen or ibuprofen 10 mg/kg po 6 hrs (HYDRATION is key-popsicles)
HSV-1 chronic treatment
docosanol (Abreva) and penciclovir (Denavir)
docosanol (Abreva)
5x a day, inhibits fusion between HSV envelope and cell membrane
acyclovir (Zovirax)
200 mg capsules every 4 hours for 5 days, indicated for immuno patients
acyclovir/pencyclovir function
phosphorylated by thymidine kinase into acyclovir-TP, which inhibits viral DNA replication by analog of dGTP
valcyclovir and pencyclovir turn into
acyclovir by liver
HSV-1 recurrent Valtrex (valacyclovir) dose
1 g caplet (2 g now, 1 g rest of days)
HSV-1 prophylaxis Valtrex (valacyclovir) dose
500 mg daily
HSV-2 treatment
acyclovir 400 mg (3x daily, 7-10 days) or valacyclovir 500 mg (2x daily, 7-10 days)